BizJournals Portfolio
Aug 17 2010 2:44pm EDT

Medtronic Invests in Bone Healing

Medtronic will spend $123 million to buy Osteotech Inc. to expand its bone-healing portfolio.

Medtronic officials said in a news release that the purchase of Osteotech will compliment Medtronic Biologics’ bone-healing portfolio, which includes products for the treatments of spine, orthopedic trauma, and dental conditions. The Osteotech acquisition expands that line-up into joint reconstruction, foot and ankle, and sports medicine.

Medtronic plans to pay $6.50 per share for Eatontown, New Jersey-based Osteotech, a 66 percent premium over Osteotech’s Monday closing price.

More details on Medtronic's $123M purchase of Osteotech are available from the Minneapolis/St. Paul Business Journal.


Chris Newmarker is a staff writer for the Minneapolis/St. Paul Business Journal.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.


Connect With Portfolio.com

Come on, like us—you know you want to.

Follow us and if you're an innovative entrepreneur, we'll return the favor.

Today's top stories, conversation starters, and the back nine business bites.

spotlight on

People & Ideas

Whisky To-Go-Go

Now there's a company that let's you taste your knowledge of fine blended Scotches by mixing a whisky of your own. Read More